A zebrafish xenograft model for evaluating efficacy of cisplatin in muscle-invasive bladder cancer

被引：0

作者：

Sugino, Y. ^{[1
]}

Sekito, S. ^{[1
]}

Kageyama, T. ^{[1
]}

Sasaki, T. ^{[1
]}

Masui, S. ^{[1
]}

Nishikawa, K. ^{[1
]}

Tanaka, T. ^{[2
]}

Shimada, Y. ^{[3
]}

Zang, L. ^{[4
]}

Inoue, T. ^{[1
]}

机构：

[1] Mie Univ, Grad Sch Med, Dept Nephrourol Surg & Androl, Tsu, Mie, Japan

[2] Mie Univ, Grad Sch Med, Dept Syst Pharmacol, Tsu, Mie, Japan

[3] Mie Univ, Grad Sch Med, Dept Integrat Pharmacol, Tsu, Mie, Japan

[4] Mie Univ, Grad Sch Reg Innovat, Tsu, Mie, Japan

来源：

EUROPEAN UROLOGY | 2024年 / 85卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

P172

引用

页码：S241 / S242

页数：2

共 50 条

[21] The management of muscle-invasive bladder cancer [J].

不详 .

BJU INTERNATIONAL, 2021, 128 (03) :290-290

[22] Management of muscle-invasive bladder cancer [J].

Moon, Andrew ;

Van der Voet, Hans ;

Cresswell, Jo .

TRENDS IN UROLOGY & MENS HEALTH, 2015, 6 (06) :7-11

[23] Treatment of muscle-invasive bladder cancer [J].

Sherif, Amir ;

Jonsson, Martin N. ;

Wiklund, N. Peter .

EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (09) :1279-1283

[24] Chemotherapy for Muscle-Invasive Bladder Cancer [J].

Trenta, Patrizia ;

Calabro, Fabio ;

Cerbone, Linda ;

Sternberg, Cora N. .

CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (01) :1-14

[25] Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer [J].

Hattori, Yuto ;

Fujiwara, Tasuku ;

Hagimoto, Hiroki ;

Kokubun, Hidetoshi ;

Murata, Shiori ;

Makita, Noriyuki ;

Abe, Yohei ;

Kubota, Masashi ;

Tohi, Yoichiro ;

Tsutsumi, Naofumi ;

Shibasaki, Noboru ;

Inoue, Koji ;

Kawakita, Mutsushi ;

Yamasaki, Toshinari .

INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) :1102-1106

[26] Bladder sparing options for muscle-invasive bladder cancer [J].

Laukhtina, Ekaterina ;

Moschini, Marco ;

Teoh, Jeremy Yuen-Chun ;

Shariat, Shahrokh F. .

CURRENT OPINION IN UROLOGY, 2024, 34 (06) :471-476

[27] Bladder preserving strategies for muscle-invasive bladder cancer [J].

Merseburger, Axel S. ;

Matuschek, Ira ;

Kuczyk, Markus A. .

CURRENT OPINION IN UROLOGY, 2008, 18 (05) :513-518

[28] Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base [J].

Smith, Angela B. ;

Deal, Allison M. ;

Woods, Michael E. ;

Wallen, Eric M. ;

Pruthi, Raj S. ;

Chen, Ronald C. ;

Milowsky, Matthew I. ;

Nielsen, Matthew E. .

BJU INTERNATIONAL, 2014, 114 (05) :719-726

[29] Clinical Outcomes of Neoadjuvant Paclitaxel/Cisplatin/Gemcitabine Compared with Gemcitabine/Cisplatin for Muscle-Invasive Bladder Cancer [J].

Kawada, Tatsushi ;

Kobayashi, Yasuyuki ;

Tsugawa, Takuji ;

Tsuboi, Kazuma ;

Katayama, Satoshi ;

Iwata, Takehiro ;

Bekku, Kensuke ;

Kobayashi, Tomoko ;

Edamura, Kohei ;

Ebara, Shin ;

Araki, Motoo .

ACTA MEDICA OKAYAMA, 2025, 79 (02) :81-92

[30] Camrelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer [J].

Xing, N. ;

Han, S. ;

Jiang, J. ;

Xu, W. ;

Shi, B. ;

Ping, H. ;

Ji, Z. ;

Ma, Q. ;

Wang, H. ;

Chen, S. ;

Wang, W. ;

Fan, X. ;

Zhou, Q. ;

Zhang, W. .

ANNALS OF ONCOLOGY, 2021, 32 :S714-S714

← 1 2 3 4 5 →